George Scangos, CEO of Biogen Idec (NASDAQ:BIIB), will talk about the state of the biotech industry during the annual CED Life Science Conference.

CED has announced Scangos as a headline speaker for the conference, scheduled for Feb. 27 and 27 at the Raleigh Convention Center.

Other scheduled speakers include Food and Drug Administration Commissioner Margaret Hamburg; Christopher Austin, director of the National Institutes of Health’s National Center for Advancing Translational Sciences; and Harvard Business School Professor Clayton Christensen, author of “The Innovator’s Dilemma.”

For more information or to register, go here.